These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22714061)

  • 21. Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells.
    Li F; Dong X; Lin P; Jiang J
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29360760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.
    Yang G; Ayala G; De Marzo A; Tian W; Frolov A; Wheeler TM; Thompson TC; Harper JW
    Clin Cancer Res; 2002 Nov; 8(11):3419-26. PubMed ID: 12429629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nodal enhances the activity of FoxO3a and its synergistic interaction with Smads to regulate cyclin G2 transcription in ovarian cancer cells.
    Fu G; Peng C
    Oncogene; 2011 Sep; 30(37):3953-66. PubMed ID: 21532621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma.
    Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X
    Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms in cardiac fibroblast growth: an obligate role for Skp2 and FOXO3a in ERK1/2 MAPK-dependent regulation of p27kip1.
    Pramod S; Shivakumar K
    Am J Physiol Heart Circ Physiol; 2014 Mar; 306(6):H844-55. PubMed ID: 24441545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skp2 and Jab1 expression are associated with inverse expression of p27(KIP1) and poor prognosis in oral squamous cell carcinomas.
    Shintani S; Li C; Mihara M; Hino S; Nakashiro K; Hamakawa H
    Oncology; 2003; 65(4):355-62. PubMed ID: 14707456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas.
    Luo X; Yang Z; Liu X; Liu Z; Miao X; Li D; Zou Q; Yuan Y
    Tumour Biol; 2017 May; 39(5):1010428317699129. PubMed ID: 28466777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Merkel cell carcinomas: expression of S-phase kinase-associated protein 2 (Skp2), p27, and proliferation markers.
    Erickson LA; Papotti M; Volante M; Jin L; Lewis JE; Lloyd RV
    Endocr Pathol; 2003; 14(3):221-29. PubMed ID: 14586067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of FOXO protein stability via ubiquitination and proteasome degradation.
    Huang H; Tindall DJ
    Biochim Biophys Acta; 2011 Nov; 1813(11):1961-4. PubMed ID: 21238503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissection of the APCCdh1-Skp2 cascade in breast cancer.
    Fujita T; Liu W; Doihara H; Date H; Wan Y
    Clin Cancer Res; 2008 Apr; 14(7):1966-75. PubMed ID: 18381934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.
    Xie C; Song LB; Wu JH; Li J; Yun JP; Lai JM; Xie DY; Lin BL; Yuan YF; Li M; Gao ZL
    PLoS One; 2012; 7(7):e40607. PubMed ID: 22815774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer.
    Ravaioli A; Monti F; Regan MM; Maffini F; Mastropasqua MG; Spataro V; Castiglione-Gertsch M; Panzini I; Gianni L; Goldhirsch A; Coates A; Price KN; Gusterson BA; Viale G;
    Ann Oncol; 2008 Apr; 19(4):660-8. PubMed ID: 18272916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytoplasmic Skp2 expression is associated with p-Akt1 and predicts poor prognosis in human breast carcinomas.
    Liu J; Wei XL; Huang WH; Chen CF; Bai JW; Zhang GJ
    PLoS One; 2012; 7(12):e52675. PubMed ID: 23300741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
    Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
    Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of FOXM1 and related proteins in breast cancer molecular subtypes.
    Lee JJ; Lee HJ; Son BH; Kim SB; Ahn JH; Ahn SD; Cho EY; Gong G
    Int J Exp Pathol; 2016 Apr; 97(2):170-7. PubMed ID: 27277416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNMT3B overexpression by deregulation of FOXO3a-mediated transcription repression and MDM2 overexpression in lung cancer.
    Yang YC; Tang YA; Shieh JM; Lin RK; Hsu HS; Wang YC
    J Thorac Oncol; 2014 Sep; 9(9):1305-15. PubMed ID: 25122426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer.
    Habashy HO; Rakha EA; Aleskandarany M; Ahmed MA; Green AR; Ellis IO; Powe DG
    Breast Cancer Res Treat; 2011 Aug; 129(1):11-21. PubMed ID: 21336599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma.
    Langner C; von Wasielewski R; Ratschek M; Rehak P; Zigeuner R
    Urology; 2004 Sep; 64(3):611-6. PubMed ID: 15351619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and prognostic implications of FOXO3a and Ki67 in lung adenocarcinomas.
    Liu HB; Gao XX; Zhang Q; Liu J; Cui Y; Zhu Y; Liu YF
    Asian Pac J Cancer Prev; 2015; 16(4):1443-8. PubMed ID: 25743813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.